HAVCR2 and myeloid sarcoma: Both Tim-3 and Tim-4 contribute to the expansion of regulatory T and B cells, supporting the use of Tim receptor agonism as a non-antigen-specific strategy for inducing immune tolerance in autoimmune diseases such as multiple sclerosis (MS) [10,11,12,13].